Results 21 to 30 of about 18,705 (234)

Psychedelic Drugs and Jungian Therapy [PDF]

open access: yes, 2020
The authors review the history of and recent research on the psychotherapeutic efficacy of psychedelic drugs. Psychedelic drugs appear to provide access to unconscious material and, when used in a therapeutic context, may cause deep and longstanding ...
Mahr, Greg, Sweigart, Jamie
core   +1 more source

Psychedelic biomedicalization: mainstreaming a scientific revolution

open access: yes, 2023
Friedman, AsiaPsychedelic drugs have again become the subject of numerous scientific and scholarly investigations with much attention given to their viability as treatments for an array of mental health conditions.
Neitzke-Spruill, Logan
core   +1 more source

CE: Psychedelic-Assisted Therapy [PDF]

open access: yes, 2021
Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S. psychedelic research
Dorsen, Caroline G   +7 more
core   +1 more source

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

open access: yesScientific Reports, 2023
Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health
Richard J. Zeifman   +7 more
doaj   +1 more source

Self-blinding citizen science to explore psychedelic microdosing

open access: yeseLife, 2021
Microdosing is the practice of regularly using low doses of psychedelic drugs. Anecdotal reports suggest that microdosing enhances well-being and cognition; however, such accounts are potentially biased by the placebo effect.
Balázs Szigeti   +7 more
doaj   +1 more source

Psychedelics [PDF]

open access: yesPharmacological Reviews, 2016
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction. Their origin predates written history, and they were employed by early cultures in many sociocultural and ...
openaire   +2 more sources

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

open access: yesEuropean Journal of Psychotraumatology, 2020
Cognitive-behavioural conjoint therapy (CBCT) for PTSD has been shown to improve PTSD, relationship adjustment, and the health and well-being of partners. MDMA (3,4-methylenedioxymethamphetamine) has been used to facilitate an individual therapy for PTSD.
Candice M. Monson   +9 more
doaj   +1 more source

Back from the rabbit hole. Theoretical considerations and practical guidelines on psychedelic integration for mental health specialists

open access: yesFrontiers in Psychology, 2023
The growing interest in and prevalence of the use of psychedelics, as well as the potential benefits and negative consequences associated with psychedelic experiences, create a need for mental health specialists to be able to provide adequate and ...
Jakub Greń   +8 more
doaj   +1 more source

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness

open access: yesFrontiers in Pharmacology, 2021
Background: Recent years have seen a resurgence of research on the potential of psychedelic substances to treat addictive and mood disorders. Historically and contemporarily, psychedelic studies have emphasized the importance of contextual elements ('set
H. Kettner   +7 more
doaj   +1 more source

Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada

open access: yesDrug and Alcohol Dependence Reports, 2022
Background: Psychedelic-assisted therapies are receiving mounting attention for their therapeutic potential. However, little is known about interest among women who experience elevated risk of mental health and substance use disorders.
Elena Argento   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy